These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37983036)

  • 1. Therapeutic Benefit From New Drugs From Pharmaceutical Companies.
    Lexchin J
    JAMA Intern Med; 2024 Jan; 184(1):52-53. PubMed ID: 37983036
    [No Abstract]   [Full Text] [Related]  

  • 2. Five years of pharmaceutical industry funding of patient organisations in Sweden: Cross-sectional study of companies, patient organisations and drugs.
    Mulinari S; Vilhelmsson A; Rickard E; Ozieranski P
    PLoS One; 2020; 15(6):e0235021. PubMed ID: 32579571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The pharmaceutical industry in France: the turning point of 1915].
    Bonnemain B
    Rev Hist Pharm (Paris); 2015 Dec; 63(388):399-422. PubMed ID: 26827550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Orphan drugs from the perspective of research-based pharmaceutical and biotech companies].
    Sydow S; Throm S
    Internist (Berl); 2019 Apr; 60(4):405-410. PubMed ID: 30859276
    [No Abstract]   [Full Text] [Related]  

  • 6. How Do Pharmaceutical Companies Overcome a Corporate Productivity Crisis? Business Diversification into Medical Devices for Growth Potential.
    Euh Y; Lee D
    Int J Environ Res Public Health; 2021 Jan; 18(3):. PubMed ID: 33503944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential and non-essential drugs marketed by the 20 largest European pharmaceutical companies in developing countries.
    Hartog R
    Soc Sci Med; 1993 Oct; 37(7):897-904. PubMed ID: 8211308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strengthening the Competitiveness of Japan's Pharmaceutical Industry: Analysis of Country Differences in the Origin of New Drugs and Japan's Highly Productive Firm.
    Okuyama R
    Biol Pharm Bull; 2023; 46(5):718-724. PubMed ID: 37121698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Market watch: Top drugs and companies by sales in 2017.
    Urquhart L
    Nat Rev Drug Discov; 2018 Mar; 17(4):232. PubMed ID: 29588516
    [No Abstract]   [Full Text] [Related]  

  • 10. Top drug companies are making drugs more accessible but are also guilty of corruption, report says.
    Gulland A
    BMJ; 2014 Nov; 349():g6834. PubMed ID: 25404236
    [No Abstract]   [Full Text] [Related]  

  • 11. Reporting of outcomes in drug promotional materials distributed by pharmaceutical companies.
    Jaykaran C; Saxena D; Yadav P; Kantharia ND
    J Postgrad Med; 2011; 57(3):256-7. PubMed ID: 21941074
    [No Abstract]   [Full Text] [Related]  

  • 12. The Ethics of War, Pharmaceutical Companies, and Prescriptions.
    Viola KV; Grant-Kels JM
    Clin Dermatol; 2022; 40(6):747-748. PubMed ID: 36070823
    [No Abstract]   [Full Text] [Related]  

  • 13. Ranking pharmaceutical companies on clinical trial diversity.
    Varma T; Miller JE
    BMJ; 2023 Feb; 380():334. PubMed ID: 36764687
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmaceutical payments to Japanese certified hematologists: a retrospective analysis of personal payments from pharmaceutical companies between 2016 and 2019.
    Kusumi E; Murayama A; Kamamoto S; Kawashima M; Yoshida M; Saito H; Sawano T; Yamashita E; Tanimoto T; Ozaki A
    Blood Cancer J; 2022 Apr; 12(4):54. PubMed ID: 35393417
    [No Abstract]   [Full Text] [Related]  

  • 15. [Dealing with current ethical issues in some pharmaceutical companies…].
    Merviel P
    Gynecol Obstet Fertil Senol; 2020 Feb; 48(2):149. PubMed ID: 31870837
    [No Abstract]   [Full Text] [Related]  

  • 16. Equipment and analytical companies meeting continuous challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
    Page T; Dubina H; Fillipi G; Guidat R; Patnaik S; Poechlauer P; Shering P; Guinn M; Mcdonnell P; Johnston C
    J Pharm Sci; 2015 Mar; 104(3):821-31. PubMed ID: 25448273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in drug revenue among major pharmaceutical companies: A 2010-2019 cohort study.
    Meyers DE; Meyers BS; Chisamore TM; Wright K; Gyawali B; Prasad V; Sullivan R; Booth CM
    Cancer; 2022 Jan; 128(2):311-316. PubMed ID: 34614198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategic trends of pharmaceutical companies: A growth model through regional focus and inter-regional alliances.
    Nakashima A; Kodama K; Sengoku S
    Drug Discov Today; 2023 Jul; 28(7):103611. PubMed ID: 37164307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Early achievements of the Danish pharmaceutical industry--2. The minor and almost forgotten pharmaceutical companies].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2009; (38):7-71. PubMed ID: 20027788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Success of ophthalmic pharmaceutical start-up companies.
    Stewart WC; Kruft B; Nelson LA; Stewart JA
    Acta Ophthalmol; 2018 Mar; 96(2):e266-e268. PubMed ID: 29068525
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.